- Fapon Biotech COVID-19 Testing Raw Materials Experimentally Proved to Be Effective on Omicron Variant Detection
(Germany, 18th November, 2021) During 15th -18th November, another year of MEDICA 2021 is taking place in Germany as scheduled. Over 50 years, MEDICA has been a leading international trade fair and attracted thousands of exhibitor companies from more than 50 countries to participate every year. As a global leading provider of excellent IVD reagent raw materials and customized solutions, Fapon Biotech is pleased to present its completed COVID-19 testing one-stop solutions and other innovative IVD products at the exhibition stand of Hall3-A81.
Despite of the severe epidemic, Messe Düsseldorf Congress still witnessed a large population of participators in crowds. Medical professionals around the world gather and share innovative achievements here, delving into the trends of world’s future medical technology. Fapon Biotech’s exhibition booth also gained many visitors’ attentions.
Attendees showed great interests in our core reagent raw materials, especially the highlighted COVID-19 testing one-stop solutions. Ever since the outbreak of COVID-19 pandemic, Fapon Biotech acts promptly to constantly provide SARS-CoV-2 test raw materials to the downstream diagnostic companies. Thousands of grams of antibodies and antigens developed from Fapon Biotech have been provided to global customers whose reagents received approvals from government bodies like FDA, NMPA, ICMR, Anvisa, PEI, BfArM, etc. In the post-epidemic era, on demand of vaccination coverage and the constantly mutation of the strains, Fapon Biotech has launched completed COVID-19 testing one-stop solutions that enables virus detection, immune system evaluation of vaccines, and variant tracking. It is honorable to have our customer positive feedbacks and more enquiries from new clients on site.
Leveraging on the solid experience in core reagent raw materials, Fapon Biotech has developed comprehensive customized solutions to better meet our client’s needs, introducing more and more open system instrument platforms and reagent services. Coupled with our compact and convenient hot sale fully automatic CLIA analyzers, this time, Fapon Biotech has rolled out two new analyzers with open system, which is specialized in rapid molecular diagnostics. There is no doubt that our instrument platforms will be the bright spot among the exhibits. Many visitors come to ask more information with considerable interests for further cooperation.
One of Fapon Biotech’s sales representative said:” We are very excited to fly to Germany again to attend MEDICA after a year skip. I can't wait to share our new products with our partners face to face. Ever since the outbreak of COVID-19, Fapon Biotech acts as an early responder in the COVID-19 battle and seek ongoing innovations to support pandemic diagnosis and control. In the post-epidemic era, we believe that in addition to our completed COVID-19 testing one-stop solutions, our high-performance IVD reagent raw materials such as tumor marker and cardiac marker will also be favored by more and more customers. All in all, we really cherish this opportunity to MEDICA and sincerely welcome more partners come to chat with us. I believe that Fapon Biotech can fulfill the company's mission as always: Enable Disease Identification Earlier, More Accurate, Convenient and Affordable.”